$FLXN - another trade thought
From a risk management perspective, I would not be willing to hold more than a small position into the data. Perhaps a smarter trader might be to model the $TRVN action. Watch the data pop and fad, looking to buy the first day fade after data, with the trade thesis that bids will come in and move the stock higher over the next couple days. One reason this might work is the p3 data due Q1-16 and the fact that the patient inclusion data is the same between P2B and P3, so good read through to P3 result expectation. Investors vs traders might step in post data which could drive a nice post data move over the near term.
-BioHutner
-BioHunter
Twitter: @TheBio_Hunter
